Argus II is a novel healthcare technology that restores vision in RP patients. Improvements in visual acuity are expected to lead to improvements in patient self-confidence, decreasing their ...

For decades, treatments for macular degeneration have focused on slowing, not restoring vision loss. A new retinal implant is flipping that script, turning patients with geographic atrophy into ...

A tiny wireless chip placed at the back of the eye is giving people with severe vision loss something they had been told they ...

In the past, patients who were blind from retinitis pigmentosa or other hereditary photoreceptor diseases had very few options. The Argus® II Retinal Prosthesis System (Second Sight Medical Products ...

USC and Second Sight Medical Products Inc., the developer of retinal prostheses for treating blindness, are expanding the clinical trial of an advanced retinal prosthesis into Europe. The announcement ...

A clinical trial led by Stanford University School of Medicine has demonstrated that a wireless retinal prosthesis can help restore vision lost to advanced macular degeneration. The results, published ...

For the first time, researchers have restored some vision to people with a common type of eye disease by using a prosthetic retinal implant. If approved for broader use in the future, the treatment ...

Good news, Dame Judi Dench: A new prosthetic retinal implant has restored limited vision to people suffering from an advanced form of macular degeneration, allowing some who were nearly blind to read ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...

The Argus II, a “bionic eye”, is intended to provide electrical stimulation of the retina to elicit visual perception in blind subjects with severe to profound retinitis pigmentosa, according to the ...